Atara Biotherapeutics (United States)
ORCID: 0000-0002-5198-0585Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial”.
Scott A. Sands, Lata Maganti, Tami Crumley, Sabrina Fox‐Bosetti, Azher Hussain +9 more